Blog - Page 3082 of 5690

FridayFeb 15, 2013 2:34 pm

Rafarma Pharmaceuticals, Inc. (RAFA) is “One to Watch”

Rafarma Pharmaceuticals, Inc. is a multiproduct pharmaceutical company specializing in the production of generic antibiotics and specialty pharmaceuticals, including its own proprietary products approved by the ministry of health. Rafarma stands as one of the most ambitious projects in recent medical history, having constructed the most technologically advanced pharmaceutical plant in Russia. Based in Terbuny, Lipetsk region, Russia, Rafarma possesses a unique niche in the burgeoning pharmaceutical market and is poised to become a major player in the international drug industry. The company was established under the auspices of the Foundation to Support Health Care and has been approved by…

FridayFeb 15, 2013 10:54 am

Liberator Medical Holdings, Inc. (LBMH) Reports First Quarter Revenue of $17.6 Million

The subsidiary of Liberator Medical Holdings, Liberator Medical Supply, established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible senior citizens. The company offers a simple, reliable way to buy medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance companies. The company yesterday announced the financial results for its first fiscal quarter ended December 31, 2012. Sales increased by $2.755 million, or 18.6%, to $17.551 million, versus sales of $14.796 million in the same year ago period. The increased sales were due to…

FridayFeb 15, 2013 10:53 am

TechPrecision Corp. (TPCS) Subsidiary Ships First AOS-100A Isotope Transport Cask to Alpha-Omega Commercial Company

TechPrecision, a global manufacturer of large-scale, metal fabricated, and machined precision components, today said its subsidiary, Ranor, has shipped the first AOS-100A Isotope Transport Cask to a commercial customer of Alpha-Omega Services Inc., reflecting a long-standing collaboration. The units were approved by the Nuclear Regulatory Commission (NRC), as Ranor has passed the NRC manufacturing process and quality audit for the cask production in March of 2012. “This shipment marks a milestone for TechPrecision’s Ranor subsidiary, for Alpha-Omega Services, and for the nuclear industry,” James Molinaro, CEO of TechPrecision stated in the press release. “This isotope transport cask enables safe transport…

FridayFeb 15, 2013 7:45 am

International Stem Cell Corp. (ISCO) Fortifies Portfolio of Intellectual Property

International Stem Cell Corp., a California-based biotechnology company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs), just announced that amendments have been made to its license agreements with Advanced Cell Technology, Inc. First entered into in 2004, the license agreements provide access to an array of patents and patent applications for the use of various technologies in certain human tissues. Through these amendments, ISCO has extended its existing rights in the area of parthenogenesis, as well as the therapeutic use of parthenogenetically derived stem cells for treating any human diseases. ISCO now has an exclusive worldwide license…

FridayFeb 15, 2013 7:45 am

Neogenomics, Inc. (NEO) Video Chart for Friday, February 15, 2013

NEO made a push on Thursday with volume increasing significantly over the prior days. At this point the chart is testing top-end resistance levels at $3.10 as it looks to breakout to new 52-week highs and continue a long-term uptrend. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

FridayFeb 15, 2013 7:44 am

Will Sutton Joins Hansen Medical, Inc. (HNSN) as COO

Intravascular robotics leader Hansen Medical announced that Will Sutton has been appointed to the newly created position of Chief Operating Officer. Reporting directly to President and CEO Bruce Barclay, Mr. Sutton will manage and oversee the company’s engineering and manufacturing functions. Hansen Medical created this position to enhance collaboration on product development and manufacturing, which is consistent with its commitment to bringing innovative products and capabilities to the market with improved product margins. “I am excited to join the Hansen Medical team at such an important inflection point in the Company’s history,” said Mr. Sutton. “I look forward to utilizing…

ThursdayFeb 14, 2013 2:41 pm

The Aristocrat Group Corp. (ASCC) CEO to Visit Idaho Distillery Next Week to Close Deal

The Aristocrat Group Corp. CEO Robert Federowicz will travel to Idaho next week to close a deal for the production of a new vodka to be promoted by Luxuria Brands. The company is working fast to get its debut distilled spirit on store shelves as quickly as possible. ASCC has already developed a sophisticated marketing plan for the new vodka, which includes a three-picture product placement deal with feature film studio Outpost Media, Inc. The first film, Killing Time, wrapped principle photography this week. “We now have everything in place for a successful launch except for the required cases of…

ThursdayFeb 14, 2013 2:38 pm

Noble Roman’s, Inc. (NROM) Maintains Steady Pace with Growth of Take-N-Bake Franchise Concept

Noble Roman’s, the Indianapolis-based franchisor of Noble Roman’s Pizza and Tuscano’s Italian Style Subs, issued an update on the expansion of its take-n-bake (TBN) concept, which is available in grocery stores as well as in the stand-alone TNB franchise structure. In the last three weeks alone, Noble Roman’s has entered into two new franchise agreements, bringing the total number of TNB units to 11, eight of which are currently under development or construction and are expected to open during the first half of 2013. In the first six weeks of 2013, the company has expanded the number of grocery stores…

ThursdayFeb 14, 2013 11:10 am

Rosetta Genomics Ltd. (ROSG) Announces Receipt of Two U.S. Patent Allowances

Leading microRNA-based molecular diagnostics provider Rosetta Genomics announced today that it has received two notices of allowance for Patent Applications 12/661,041 and 12/850,091 from the U.S. Patent and Trademark Office. Titled “microRNAs and Uses Thereof,” 12/661,041 has allowed claims covering the composition of matter for miR-29c, as well as sequence variants (90 percent identical thereto), a vector, and a probe comprising the same. miR-29c is a core element in miRview mets2 diagnostic assay for the identification of the tumor of origin in cancer of unknown and uncertain primary (“CUP”), which is Rosetta Genomics’ lead commercial product. Titled “Viral and Viral…

ThursdayFeb 14, 2013 11:09 am

VistaGen Therapeutics, Inc. (VSTA) – A Prime Example of Stem Cell Application Diversity

The advent of stem cell technology is proving to be one of the most foundational developments in the history of modern medicine. Like the stem cell itself, this rapidly developing technology is showing a remarkable ability to transform itself, revealing new opportunities in a rising number of medical applications. Although some awareness of the ability of some cells to change into other cells has been known for a long time, it’s only been in the past several decades that researchers have begun to appreciate the range of capabilities that stem cells represent. The result has been an explosion of possibilities…

Site Search

Company Search